MicroRNA-934 facilitates cell proliferation, migration, invasion and angiogenesis in colorectal cancer by targeting B-cell translocation gene 2

References

• Aran V, Victorino AP, Thuler LC, et al. Colorectal cancer: epidemiology, disease mechanisms and interventions to reduce onset and mortality. Clin Colorectal Cancer. 2016;15(3):195–203.
   PubMed Web of Science ®Google Scholar
• Dekker E, Tanis PJ, Vleugels JLA, et al. Colorectal cancer. Lancet. 2019;394(10207):1467–1480.
   PubMed Web of Science ®Google Scholar
• Keum N, Giovannucci E. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nat Rev Gastroenterol Hepatol. 2019;16:713–732.
   PubMed Web of Science ®Google Scholar
• Geng F, Wang Z, Yin H, et al. Molecular targeted drugs and treatment of colorectal cancer: recent progress and future perspectives. Cancer Biother Radiopharm. 2017;32(5):149–160.
   PubMed Web of Science ®Google Scholar
• Yan H, Ren S, Lin Q, et al. Inhibition of UBE2N-dependent CDK6 protein degradation by miR-934 promotes human bladder cancer cell growth. FASEB J. 2019;33(11):12112–12123.
   PubMed Web of Science ®Google Scholar
• Hu Y, Zhang Q, Cui J, et al. Oncogene miR-934 promotes ovarian cancer cell proliferation and inhibits cell apoptosis through targeting BRMS1L. Eur Rev Med Pharmacol Sci. 2019;23:5595–5602.
   PubMedGoogle Scholar
• Muñoz-Rodríguez JL, Vrba L, Futscher BW, et al. Differentially expressed microRNAs in postpartum breast cancer in Hispanic women. PloS One. 2015;10(4):e0124340–e.
   PubMed Web of Science ®Google Scholar
• Slattery ML, Herrick JS, Pellatt DF, et al. MicroRNA profiles in colorectal carcinomas, adenomas and normal colonic mucosa: variations in miRNA expression and disease progression. Carcinogenesis. 2016;37(3):245–261.
   PubMed Web of Science ®Google Scholar
• Zhao S, Mi Y, Guan B, et al. Tumor-derived exosomal miR-934 induces macrophage M2 polarization to promote liver metastasis of colorectal cancer. J Hematol Oncol. 2020;13(1):156.
   PubMed Web of Science ®Google Scholar
• Arneth B. Tumor Microenvironment. Medicina (Kaunas). 2019;56(1):15.
   Web of Science ®Google Scholar
• Lee SS, Cheah YK. The interplay between MicroRNAs and cellular components of tumour microenvironment (TME) on Non-Small-Cell Lung Cancer (NSCLC) progression. J Immunol Res. 2019;2019:3046379.
   PubMed Web of Science ®Google Scholar
• Viallard C, Larrivee B. Tumor angiogenesis and vascular normalization: alternative therapeutic targets. Angiogenesis. 2017;20(4):409–426.
   PubMed Web of Science ®Google Scholar
• Sun W, Wang X, Li J, et al. MicroRNA-181a promotes angiogenesis in colorectal cancer by targeting SRCIN1 to promote the SRC/VEGF signaling pathway. Cell Death Dis. 2018;9(4):438.
   PubMedGoogle Scholar
• Huang L, Zhang Y, Li Z, et al. MiR-4319 suppresses colorectal cancer progression by targeting ABTB1. United European Gastroenterol J. 2019;7(4):517–528.
   PubMed Web of Science ®Google Scholar
• Zhang L, Huang H, Wu K, et al. Impact of BTG2 expression on proliferation and invasion of gastric cancer cells in vitro. Mol Biol Rep. 2010;37(6):2579–2586.
   PubMed Web of Science ®Google Scholar
• Kawakubo H, Brachtel E, Hayashida T, et al. Loss of B-cell translocation gene-2 in estrogen receptor-positive breast carcinoma is associated with tumor grade and overexpression of cyclin d1 protein. Cancer Res. 2006;66(14):7075–7082.
   PubMed Web of Science ®Google Scholar
• Ficazzola MA, Fraiman M, Gitlin J, et al. Antiproliferative B cell translocation gene 2 protein is down-regulated post-transcriptionally as an early event in prostate carcinogenesis. Carcinogenesis. 2001;22(8):1271–1279.
   PubMed Web of Science ®Google Scholar
• Jiang Z, Zhang L, Zhang L, et al. Enhancement of B-cell translocation gene-2 inhibits proliferation and metastasis of colon cancer cells. Zhonghua Zhong Liu Za Zhi. 2015;37:330–335.
   PubMedGoogle Scholar
• Shang D, Xie C, Hu J, et al. Pancreatic cancer cell-derived exosomal microRNA-27a promotes angiogenesis of human microvascular endothelial cells in pancreatic cancer via BTG2. J Cell Mol Med. 2020;24(1):588–604.
   PubMed Web of Science ®Google Scholar
• Liu Z, Wang Y, Dou C, et al. Hypoxia-induced up-regulation of VASP promotes invasiveness and metastasis of hepatocellular carcinoma. Theranostics. 2018;8(17):4649–4663.
   PubMed Web of Science ®Google Scholar
• Wan G, Liu Y, Zhu J, et al. SLFN5 suppresses cancer cell migration and invasion by inhibiting MT1-MMP expression via AKT/GSK-3β/β-catenin pathway. Cell Signal. 2019;59:1–12.
   PubMed Web of Science ®Google Scholar
• Lin X, Yang F, Qi X, et al. LncRNA DANCR promotes tumor growth and angiogenesis in ovarian cancer through direct targeting of miR-145. Mol Carcinog. 2019;58(12):2286–2296.
   PubMed Web of Science ®Google Scholar
• Li J-H, Liu S, Zhou H, et al. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42(D1):D92–D7.
   PubMed Web of Science ®Google Scholar
• Zhang N, Hu X, Du Y, et al. The role of miRNAs in colorectal cancer progression and chemoradiotherapy. Biomed Pharmacother. 2021;134:111099.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Li J, Huang Y, et al. Upregulated miR-1258 regulates cell cycle and inhibits cell proliferation by directly targeting E2F8 in CRC. Cell Prolif. 2018;51(6):e12505–e.
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhou W, Liu Y, et al. Oncogenic role of microRNA-532-5p in human colorectal cancer via targeting of the 5ʹUTR of RUNX3. Oncol Lett. 2018;15:7215–7220.
   PubMedGoogle Scholar
• Jin Y, Weng Y, Wang Y, et al. miR-934 as a prognostic marker facilitates cell proliferation and migration of pancreatic tumor by targeting PROX1. Onco Targets Ther. 2020;13:3389–3399.
   PubMed Web of Science ®Google Scholar
• Feitelson MA, Arzumanyan A, Kulathinal RJ, et al. Sustained proliferation in cancer: mechanisms and novel therapeutic targets. Semin Cancer Biol. 2015;35(Suppl):S25–S54.
   PubMed Web of Science ®Google Scholar
• Pickup MW, Mouw JK, Weaver VM. The extracellular matrix modulates the hallmarks of cancer. EMBO Rep. 2014;15(12):1243–1253.
   PubMed Web of Science ®Google Scholar
• John R, Malathi N, Ravindran C, et al. Mini review: multifaceted role played by cyclin D1 in tumor behavior. Indian J Dent Res. 2017;28(2):187–192.
   PubMedGoogle Scholar
• Soheilifar MH, Grusch M, Neghab HK, et al. Angioregulatory microRNAs in colorectal cancer. Cancers (Basel). 2019;12(1):71.
   PubMed Web of Science ®Google Scholar
• Finley SD, Popel AS. Effect of tumor microenvironment on tumor VEGF during anti-VEGF treatment: systems biology predictions. J Natl Cancer Inst. 2013;105(11):802–811.
   PubMedGoogle Scholar
• Liang H, Ge F, Xu Y, et al. miR-153 inhibits the migration and the tube formation of endothelial cells by blocking the paracrine of angiopoietin 1 in breast cancer cells. Angiogenesis. 2018;21(4):849–860.
   PubMed Web of Science ®Google Scholar
• Amirkhah R, Schmitz U, Linnebacher M, et al. MicroRNA-mRNA interactions in colorectal cancer and their role in tumor progression. Genes Chromosomes Cancer. 2015;54(3):129–141.
   PubMed Web of Science ®Google Scholar
• Fletcher BS, Lim RW, Varnum BC, et al. Structure and expression of TIS21, a primary response gene induced by growth factors and tumor promoters. J Biol Chem. 1991;266(22):14511–14518.
   PubMed Web of Science ®Google Scholar
• Yuniati L, Scheijen B, van der Meer LT, et al. Tumor suppressors BTG1 and BTG2: beyond growth control. J Cell Physiol. 2019;234(5):5379–5389.
   PubMed Web of Science ®Google Scholar
• Huang CS, Zhai JM, Zhu XX, et al. BTG2 is down-regulated and inhibits cancer stem cell-like features of side population cells in hepatocellular carcinoma. Dig Dis Sci. 2017;62(12):3501–3510.
   PubMed Web of Science ®Google Scholar
• Devanand P, Oya Y, Sundaramoorthy S, et al. Inhibition of TNFα-interacting protein α (Tipα)-associated gastric carcinogenesis by BTG2(/TIS21) via downregulating cytoplasmic nucleolin expression. Exp Mol Med. 2018;50(2):e449–e.
   PubMedGoogle Scholar
• Mao B, Zhang Z, Wang G. BTG2: a rising star of tumor suppressors (review). Int J Oncol. 2015;46(2):459–464.
   PubMed Web of Science ®Google Scholar
• Guardavaccaro D, Corrente G, Covone F, et al. Arrest of G1-S Progression by the p53-inducible gene PC3 is Rb dependent and relies on the inhibition of cyclin D1 transcription. Mol Cell Biol. 2000;20(5):1797–1815.
   PubMed Web of Science ®Google Scholar
• Sima J, Zhang B, Sima XY, et al. Overexpression of BTG2 suppresses growth, migration, and invasion of human renal carcinoma cells in vitro. Neoplasma. 2016;63(3):385–393.
   PubMed Web of Science ®Google Scholar